Bilaketaren emaitzak - Luc W.M. Eurlings

  • Erakusten 1 - 9 emaitzak -- 9
Findu emaitzak
  1. 1
    Impact of worsening renal function related to medication in heart failure

    Impact of worsening renal function related to medication in heart failure nork Hans‐Peter Brunner‐La Rocca, Christian Knackstedt, Luc W.M. Eurlings, Vinzent Rolny, Friedemann Krause, Matthias Pfisterer, Daniel Tobler, Peter Rickenbacher, Micha T. Maeder

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure

    Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure nork Khibar Salah, Wouter E.M. Kok, Luc W.M. Eurlings, Paulo Bettencourt, Joana Pimenta, Marco Metra, Valerio Verdiani, Jan G.P. Tijssen, Yigal M. Pinto

    Argitaratua 2015
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction

    Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction nork Khibar Salah, Susan Stienen, Yigal M. Pinto, Luc W.M. Eurlings, Marco Metra, Antoni Bayés‐Genís, Valerio Verdiani, Jan G.P. Tijssen, Wouter E.M. Kok

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation

    Atrial Fibrillation and Heart Failure in Cardiology Practice: Reciprocal Impact and Combined Management From the Perspective of Atrial Fibrillation nork Robby Nieuwlaat, Luc W.M. Eurlings, John G.F. Cleland, Stuart M. Cobbe, Panos Vardas, Alessandro Capucci, José López‐Sendón, Joan G. Meeder, Yigal M. Pinto, Harry J.G.M. Crijns

    Argitaratua 2009
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load

    Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load nork Robert Dennert, Sebastiaan Velthuis, Simon Schalla, Luc W.M. Eurlings, Robert‐Jan van Suylen, Pieter van Paassen, Jan William Cohen Tervaert, Petra Wolffs, Valère J. Goossens, Catrien Bruggeman, Johannes Waltenberger, Harry J.G.M. Crijns, Stéphane Heymans

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

    Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis nork Richard W. Troughton, Chris Frampton, Hans‐Peter Brunner‐La Rocca, Matthias Pfisterer, Luc W.M. Eurlings, Hans Erntell, Hans Persson, Cathal O’Connor, Deddo Moertl, Patric Karlström, Ulf Dahlström, Hannah K. Gaggin, James L. Januzzi, Rudolf Berger, Mark Richards, Yigal M. Pinto, M. Gary Nicholls

    Argitaratua 2014
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening

    Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening nork Lucas Van Aelst, Sandra Voss, Paolo Carai, Rick van Leeuwen, Davy Vanhoutte, Sandra Sanders‐van Wijk, Luc W.M. Eurlings, Melissa Swinnen, Fons K. Verheyen, Eric Verbeken, Holger Nef, Christian Troidl, Stuart A. Cook, Hans‐Peter Brunner‐La Rocca, Helge Möllmann, Anna‐Pia Papageorgiou, Stéphane Heymans

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Which heart failure patients profit from natriuretic peptide guided therapy? A meta‐analysis from individual patient data of randomized trials

    Which heart failure patients profit from natriuretic peptide guided therapy? A meta‐analysis from individual patient data of randomized trials nork Hans‐Peter Brunner‐La Rocca, Luc W.M. Eurlings, Mark Richards, James L. Januzzi, Matthias Pfisterer, Ulf Dahlström, Yigal M. Pinto, Patric Karlström, Hans Erntell, Rudolf Berger, Hans Persson, Christopher M. O’Connor, Deddo Moertl, Hanna K. Gaggin, Christopher Frampton, M. Gary Nicholls, Richard W. Troughton

    Argitaratua 2015
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets

    Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets nork Luc W.M. Eurlings, Petra E.J. van Pol, Wouter E.M. Kok, Sandra van Wijk, Cara Lodewijks-van der Bolt, Aggie H.M.M. Balk, Dirk J. Lok, Harry J.G.M. Crijns, D.J.W. van Kraaij, Nicolaas de Jonge, Joan G. Meeder, Martin H. Prins, Yigal M. Pinto

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: